Does LENOGRASTIM Cause Malignant neoplasm progression? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Malignant neoplasm progression have been filed in association with LENOGRASTIM (GUNA-GCSF). This represents 2.6% of all adverse event reports for LENOGRASTIM.
19
Reports of Malignant neoplasm progression with LENOGRASTIM
2.6%
of all LENOGRASTIM reports
1
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LENOGRASTIM?
Of the 19 reports, 1 (5.3%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENOGRASTIM. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does LENOGRASTIM Cause?
Pyrexia (95)
Vomiting (61)
Neutropenia (59)
Dyspnoea (55)
Fatigue (55)
Nausea (53)
Pneumonia (51)
Arthralgia (50)
Febrile neutropenia (50)
Off label use (50)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LENOGRASTIM Alternatives Have Lower Malignant neoplasm progression Risk?
LENOGRASTIM vs LENVATINIB
LENOGRASTIM vs LEPONEX
LENOGRASTIM vs LERCANIDIPINE
LENOGRASTIM vs LETAIRIS
LENOGRASTIM vs LETERMOVIR